community based study. Journal of Paediatrics and Child Health. 2004;40(12):696-701. X-5 133. Kaidar M, Zalsman G. Olanzapine for Childhood Disintegrative Disorder. Israel Journal of Psychiatry and Related Sciences. 2004;41(1):71-2. X-1, X-2, X-3, X-4 134. Kwon H. Tardive dyskinesia in an autistic patient treated with risperidone. The American Journal of Psychiatry. 2004;161(4):757-8. X-5 135. Malow BA. Sleep Disorders, Epilepsy, and Autism. Mental Retardation and Developmental Disabilities Research Reviews. 2004;10(2):122-5. X-2, X-5 136. Noland RM, Gabriels RL. Screening and Identifying Children with Autism Spectrum Disorders in the Public School System: The Development of a Model Process. Journal of Autism and Developmental Disorders. 2004;34(3):265-77. X-5 137. Nuzzolo-Gomez R, Greer DR. Emergence of Untaught Mands or Tacts of Novel Adjective-Object Pairs as a Function of Instructional History. Analysis of Verbal Behavior. 2004;20:63-76. X-3 138. Reading R. Review of Age at first measles-mumps-rubella vaccination in children with autism and school- matched control subjects: A population-based study in metropolitan Atlanta. Child: Care, Health and Development. 2004;30(4):398-9. X-5 139. Renna R. Autism spectrum disorders Learning to Listen as We Shape Behaviors Blending Choice Theory with Applied Behavioral Analysis. International Journal of Reality Therapy. 2004;23(2):17-22. X-2, X-5 140. Schwartz IS, Sandall SR, McBride BJ, et al. Project DATA (Developmentally Appropriate Treatment for Autism): An Inclusive School-Based Approach to Educating Young Children with Autism. Topics in Early Childhood Special Education. 2004;24(3):156-68. X-5 141. Smeeth L, Cook C, Fombonne E, et al. MMR vaccination and pervasive developmental disorders: A case- control study. The Lancet. 2004;364(9438):963-9. X-5 142. Smith C, Goddard S, Fluck M. A Scheme to Promote Social Attention and Functional Language in Young Children with Communication Difficulties and Autistic Spectrum Disorder. Educational Psychology in Practice. 2004;20(4):319-33. X-3, X-4 143. Smith DL, Gillon GT. Autistic Spectrum Disorder: Caseload Characteristics, and Interventions Implemented by Speech-Language Therapists. Kairaranga. 2004;5(2):46-54. X-1, X-2, X-3, X-4 144. Sulzbacher S, Mas J, Larson EH, et al. Pediatric Tele-Health Consultation to Rural Schools and Clinics in the Pacific Northwest. Journal of Special Education Technology. 2004;19(1):35-42. X-5 145. Summers AJ, Houlding MC, Reitzel MJA. Behaviour Management Services for Children with Autism-PDD: Program Description and Patterns of Referral. Focus on Autism and Other Developmental Disabilities. 2004;19(2):95-101. X-4 146. Taylor BA, Hughes CE, Richard E, et al. Teaching Teenagers with Autism to Seek Assistance when Lost. Journal of Applied Behavior Analysis. 2004;37(1):79-82. X-5 147. Tharp BR. Epileptic Encephalopathies and Their Relationship to Developmental Disorders: Do Spikes Cause Autism? Mental Retardation and Developmental Disabilities Research Reviews. 2004;10(2):132-4. X-2, X-5 148. Tuchman R. AEDS and Psychotropic Drugs in Children with Autism and Epilepsy. Mental Retardation and Developmental Disabilities Research Reviews. 2004 May 2004;10(2):135-8. X-5 149. Waltz M, Shattock P. Autistic disorder in nineteenth-century London. Autism. 2004;8(1):7-20. X-3, X-5 150. Woo EJ, Ball R, Bostrom A, et al. Vaccine Risk Perception Among Reporters of Autism After Vaccination: Vaccine Adverse Event Reporting System 1990-2001. American Journal of Public Health. 2004;94(6):990-55. X-5 151. Yang P, Tsai J-H. Occurrence of Priapism with Risperidone-Paroxetine Combination in an Autistic Child. Journal of Child and Adolescent Psychopharmacology. 2004;14(3):342-3. X-5